Resources
Cannabinoid1 (CB‐1) receptor antagonists: a molecular approach to treating acute cannabinoid overdose
Published in 2019 by the Journal of Neural Transmission.
Fighting the Opioid Crisis – FOX Business
October 21, 2019 – Opiant CEO Roger Crystal on The Claman Countdown discusses the fight on the opioid crisis.
Opioid Crisis: Could It Have Been Prevented? – Stateside i24News
August 21, 2019 – Opiant CEO Roger Crystal on Stateside i24News discusses the fight on the opioid crisis.
Battling Opioid Abuse – KTVU-TV
August 19, 2019 – Opiant CEO Dr. Roger Crystal discusses fighting opioid abuse with NARCAN®.
Combating America’s Opioid Crisis – Fox & Friends
April 11, 2019 – Opiant CEO Dr. Roger Crystal discusses treating opioid addiction with marijuana.
Fighting fire with fire: development of intranasal nalmefene to treat synthetic opioid overdose
Published in April 2019 by ASPET Journals.
Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects
Published in March 2019 by American College of Neuropsychopharmacology.
Enhanced Intranasal Absorption of Naltrexone by Dodecyl Maltopyranoside: Implications for the Treatment of Opioid Overdose
Published in 2019 by the Journal of Clinical Pharmacology.
Opiant Pharma Teaming with HHS on New Fentanyl Overdose Spray – Fox Business with Varney & Co.
October 10, 2018 – Opiant CEO Dr. Roger Crystal discusses teaming with HHS on new opioid overdose nasal spray.
Fighting the Opioid Crisis – Fox Business Network’s “Mornings with Maria”
August 3, 2018 – Opiant CEO Dr. Roger Crystal discusses NARCAN® following singer Demi Lovato’s hospitalization.